Who Owns The Beauty Health Company Company?

Who owns The Beauty Health Company?

The Beauty Health Company went public via a May 2021 $1.1 billion SPAC merger led by Brent Saunders, shifting control from private equity to public investors. Ownership now blends institutional giants, retail holders and lingering private-equity stakes.

Institutional investors such as Vanguard and BlackRock hold large positions, while remaining private-equity interests and an active board steer strategy amid ~$400 million annual revenues and 30,000+ installed systems.

See product analysis: The Beauty Health Company Porter's Five Forces Analysis

Founded as Edge Systems in 1997 by Roger Ignon and Bill Cohen, the company’s early ownership was tightly held by the founders and a small group of employees; they funded growth largely through organic cash flow and retained controlling interest for nearly two decades.

Founding Team

Roger Ignon and Bill Cohen co-founded Edge Systems to commercialize advanced skin-resurfacing technologies and built the business from the ground up.

Early Capital

Initial funding was minimal and primarily internal; the founders prioritized product development and organic revenue over external capital through the 2000s.

Key Technology

The patented 4-in-1 Vortex-Fusion delivery system emerged as the company’s core competitive moat and drove commercial adoption in aesthetic clinics.

Ownership Concentration

Equity was concentrated among founders and early employees; specific 1997 share counts are not publicly available but control remained with the founders for ~20 years.

2016 Change

In 2016 L Catterton acquired a majority stake, introducing a professionalized capital structure and a focus on global scaling and EBITDA growth.

Founders’ Role Post-Deal

The founders partially liquidated equity but remained in advisory roles as governance shifted toward L Catterton’s investment committee.

Post-2016 governance centralized under L Catterton, new management vesting schedules were implemented, and the company transitioned from a founder-led private firm to a private-equity-backed platform preparing for broader investor ownership.

Founders and Ownership — Key Facts

Chronology and ownership shifts from founding to private equity acquisition.

• Co-founded in 1997 by Roger Ignon and Bill Cohen.
• Patented 4-in-1 Vortex-Fusion system formed the competitive moat.
• Majority stake acquired by L Catterton in 2016, professionalizing capital structure.
• Founders retained advisory roles while equity was partially liquidated.

For more on market positioning and target customers see Target Market of The Beauty Health Company.

Complete The Beauty Health Company Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

The company’s ownership shifted dramatically after the May 4, 2021 business combination that created The Beauty Health Company and listed it on NASDAQ under SKIN; a $350 million PIPE led by Fidelity and Baron Capital and a pro forma enterprise value near $1.1 billion set the initial public ownership mix, with L Catterton retaining about 40%.

By late 2025 internal ownership remained low at roughly 3%, and the shareholder base shifted from concentrated private equity control toward diversified institutional holders, influencing strategy from acquisitive growth to margin-focused core operations.

Ownership evolution highlights

The 2021 SPAC merger established public ownership; by 2025 institutions dominated shareholdings, reshaping strategic priorities toward core HydraFacial operations and profitability.

• May 4, 2021 SPAC combination created The Beauty Health Company
• $350 million PIPE led by Fidelity and Baron Capital supported the deal
• Pro forma enterprise value at close was about $1.1 billion
• Institutional investors held ~78% of common stock by end of 2025

For additional context on corporate aims and governance, see Mission, Vision & Core Values of The Beauty Health Company.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The Board of Directors of The Beauty Health Company consists of 10 members blending industry executives and financial specialists; Marla Beck serves as CEO and board member while institutional investors hold sizable, non-controlling stakes.

The company uses a single-class, one-share-one-vote structure with roughly 133,000,000 shares outstanding as of late 2025; no individual controls a majority, leaving voting power proportionate to equity and concentrated among large institutions.

Board influence and voting dynamics

The single-class voting structure means institutional holders like Vanguard and BlackRock exert significant influence over governance, executive pay and ESG priorities.

• Single-class voting: one-share-one-vote; no super-voting founders
• Approximately 133 million shares outstanding (late 2025)
• Board of 10 members mixing industry and finance expertise
• Heightened Audit and Compensation committee oversight after 2023 operational setbacks

For context on strategy and ownership evolution see Growth Strategy of The Beauty Health Company.

The Beauty Health Company Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Ownership of the Beauty Health Company has consolidated since 2023 as momentum retail rotated out and institutional, value-oriented shareholders increased stakes; by 2025 the investor base favors long-term holders targeting recurring consumables revenue and profitability.

Market signals point to potential strategic M&A interest from larger beauty conglomerates or private equity given sector consolidation and the company’s recurring consumables revenue model; activist attention in the mid-cap beauty space adds downside governance risk if 2025 financial targets are missed.

Ownership shift details

Momentum retail exited after late-2023 device issues; institutions increased holdings, emphasizing recurring revenue from consumables and path to profit.

Restructuring impact

The 2024 restructuring targets $20,000,000 in annual savings and has been publicly supported by major institutional shareholders seeking improved adjusted EBITDA margins.

Valuation context

Current market multiples near 1.5–2.0 times sales, well below post-IPO highs, making the company a plausible acquisition target or candidate for private take-private interest.

Governance risks

Activist interest across mid-cap beauty raises likelihood of ownership changes—potential minority strategic stakes to fund next-gen device R&D if targets slip.

For readers seeking deeper detail on revenue composition and recurring-consumables dynamics that influence investor appetite, see Revenue Streams & Business Model of The Beauty Health Company

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE